Clinical Trial Update: Creatine in Treating Patients With Cancer-Associated Weight Loss [Phase 3]

View source ↗

Summary

Phase 3 trial investigating creatine for cancer-associated weight loss; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Cachexia
• Weight Changes Associated with Cancer

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anorexia, Cachexia | Phase 3 | Status: COMPLETED